Search Results

Coeptis Therapeutics Holdings, Inc. is pleased to acknowledge and congratulate Professor Alexander Deiters, on receiving the University of Pittsburgh’s 2024 Chancellor’s Distinguished Research Award.

Coeptis Therapeutics Holdings, Inc. today announced that it has expanded its exclusive license agreement with the University of Pittsburgh to include autoimmune indications as part of its ongoing development of SNAP-CAR T and SNAP-CAR NK.

Harvard Apparatus Regenerative Technology, Inc. announced that it officially executed a sponsored research agreement with Drs. Stephen Badylak, George Hussey and Vincent Anto at the McGowan Institute for Regenerative Medicine, a center of the University of Pittsburgh and UPMC focused on developing regenerative therapies to address organ and tissue failure.

ECM Therapeutics announces a collaboration with the Louis J. Fox Center for Vision Restoration at the UPMC and Pitt Vision Institute led by José-Alain Sahel, MD, a distinguished professor and chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine.

Coeptis Therapeutics Holdings, Inc. today announced that it has expanded its exclusive license agreement with the University of Pittsburgh to include the SNAP-CAR technology platform in natural killer (NK) cells.

Genprex, Inc. today announced it has entered into an exclusive license agreement with the University of Pittsburgh.

Synchron announced enrollment in the COMMAND trial has commenced at the University of Pittsburgh, Pittsburgh, PA.

Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced that it has opened a new state-of-the-art laboratory facility in Pittsburgh.